Ascepion Pharmaceuticals, Inc. is a biotechnology company dedicated to the discovery and development of breakthrough small molecule drugs targeting signal transduction pathways for oncology and related disease indications. The company is building a fully integrated drug discovery and development platform in order to establish a rich pipeline of drug candidates and therapeutics. The Company’s integrated drug discovery and development infrastructure comprises discovery biology and lead generation capabilities, as well as preclinical development expertise.By integrating kinase biology and chemistry expertise with efficient ADME/PK and in vivo biology support strategies, Ascepion Pharmaceuticals intends to become an industrial leader in developing breakthrough kinase targeted therapeutics.